Bell Rock Capital’s AbbVie ABBV Stock Holding History

Bell Rock Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-514	Closed	-$45K	–	71
2019 Q4	$45K	Sell	514 -8	-2%	-$664	0.04%	223
2019 Q3	$39K	Buy	522 +9	+2%	+$617	0.03%	222
2019 Q2	$37K	Sell	513 -3,564	-87%	-$280K	0.03%	223
2019 Q1	$327K	Buy	4,077 +343	+9%	+$28.1K	0.19%	94
2018 Q4	$346K	Sell	3,734 -1,131	-23%	-$99.5K	0.23%	85
2018 Q3	$460K	Hold	4,865	–	–	0.23%	79
2018 Q2	$452K	Hold	4,865	–	–	0.23%	83
2018 Q1	$461K	Sell	4,865 -340	-7%	-$37.4K	0.24%	79
2017 Q4	$502K	Sell	5,205 -10	-0.2%	-$942	0.27%	70
2017 Q3	$465K	Buy	5,215 +1,144	+28%	+$87.1K	0.27%	75
2017 Q2	$295K	Buy	4,071 +3,250	+396%	+$218K	0.18%	95
2017 Q1	$53K	Hold	821	–	–	0.05%	188
2016 Q4	$51K	Buy	+821	New	+$50.1K	0.05%	181

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bell Rock Capital's ABBV Position: Q1 2020 in Review

Bell Rock Capital sold out of AbbVie (ABBV) in Q1 2020, closing a stake of 514 shares — an estimated $45K sold.

Bell Rock Capital first reported a position in ABBV in Q4 2016 and held it in 13 quarters. The position peaked at $502K in Q4 2017. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

Bell Rock Capital reported no remaining AbbVie position as of Q1 2020 after selling out during the quarter.
Bell Rock Capital sold 514 AbbVie shares in Q1 2020, an estimated $45K.
Bell Rock Capital first reported a position in AbbVie in Q4 2016 and held it in 13 quarters.
Bell Rock Capital's AbbVie position peaked at $502K in Q4 2017.
2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Bell Rock Capital's 13F filing for Q1 2020, filed 7 May 2020.